Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1456 AL 1470

Microglial phagocytosis in Alzheimer disease

Brown GC, St George-Hyslop P, Paolicelli RC, Lemke G.

Nat Rev Neurol. 2026 Jan;22(1):54-69. doi: 10.1038/s41582-025-01162-y. Epub 2025 Nov 28.

Postmenopausal sarcopenia and Alzheimer's disease: The interplay of mitochondria, insulin resistance, and myokines

Farhana F, Sultana MA, Hia RA, Hegde V.

Neurosci Biobehav Rev. 2026 Jan;180:106501. doi: 10.1016/j.neubiorev.2025.106501. Epub 2025 Nov 29.

The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis

Wang T, Feng L, Tian Z.

Ageing Res Rev. 2026 Jan;114:102980. doi: 10.1016/j.arr.2025.102980. Epub 2025 Dec 1.

Need for analysis of linguistic factors for elucidating the pathogenesis of Alzheimer's disease: A position paper

Yokoi T.

J Alzheimers Dis. 2026 Feb;109(4):1603-1607. doi: 10.1177/13872877251407350. Epub 2025 Dec 19.

Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer's Disease

Katuwawala K, Bharadwaj P, Martins I, De Silva BGDNK, Ho V, Dissanayake A, Martins RN, Fernando WMADB.

Mol Neurobiol. 2025 Dec 22;63(1):319. doi: 10.1007/s12035-025-05626-6.

An overview of gene and cell therapy approaches for Alzheimer's disease

Heidari Z, Zakaee A, Vafadar A, Alavimanesh S, Charami H, Jamali Z, Jahromi AH, Rakhsha A, Savardashtaki A.

Metab Brain Dis. 2025 Dec 26;41(1):10. doi: 10.1007/s11011-025-01763-y.

Interacting partners of Tau protein in Alzheimer's disease

Chinnathambi S, Velmurugan G, Kumarappan M, Chandrashekar M.

Adv Clin Chem. 2026;131:87-102. doi: 10.1016/bs.acc.2025.10.005. Epub 2025 Nov 7.

Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2026;151:197-224. doi: 10.1016/bs.apcsb.2025.10.005. Epub 2025 Nov 4.

Therapeutics immunotargets for Tauopathy

Chinnathambi S, Rangappa N.

Adv Protein Chem Struct Biol. 2026;151:267-302. doi: 10.1016/bs.apcsb.2025.10.015. Epub 2025 Nov 4.

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Arar S, Haque MA, Kayed R.

Proteins. 2025 Aug;93(8):1314-1329. doi: 10.1002/prot.26561. Epub 2023 Aug 2.

Entwined processes in Alzheimer's disease: Brain cellular senescence and Alzheimer's disease pathology

Li W, Han Y, Wang P, Song Q.

Alzheimers Dement. 2025 Oct;21(10):e70803. doi: 10.1002/alz.70803.

Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer's disease

Zakharova NV, Kononikhin AS, Indeykina MI, Bugrova AE, Strelnikova P, Pekov S, Kozin SA, Popov IA, Mitkevich V, Makarov AA, Nikolaev EN.

Mass Spectrom Rev. 2025 Jan-Feb;44(1):3-21. doi: 10.1002/mas.21775. Epub 2022 Mar 28.

An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.

Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.

Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies

Anitha K, Singh MK, Kohat K, Sri Varshini T, Chenchula S, Padmavathi R, Amerneni LS, Vishnu Vardhan K, Mythili Bai K, Chavan MR, Bhatt S.

Mol Neurobiol. 2025 Feb;62(2):2314-2332. doi: 10.1007/s12035-024-04384-1. Epub 2024 Aug 5.

Tetrameric Transthyretin as a Protective Factor Against Alzheimer's Disease

Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen YF, Panichella G, Musetti V, Castiglione V, Vergaro G, Emdin M, Franzini M.

Mol Neurobiol. 2025 Mar;62(3):2945-2954. doi: 10.1007/s12035-024-04442-8. Epub 2024 Aug 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias